Drug company executives have pledged to cut back on the controversial practice of handing out free medicines to doctors across the European Union, as part of broader efforts to tighten the industry’s ethical standards. A board meeting of the European Federation of Pharmaceutical Industries and Associations, the EU industry body, agreed to tougher new practices designed to improve criticisms of the sector’s marketing practices. Andrew Witty, chief executive of GlaxoSmithKline who recently took over as president of Efpia, said: “Our industry needs to be in touch with society’s expectations and with peoples’ appropriate demands for both greater transparency and for a greater commitment to high ethical standards. Today’s leadership statement is made in this spirit. It strongly reaffirms our commitment to our existing Codes of Practice and to their continuous improvement. We believe that full adherence to these codes is essential, and that breaches should not be tolerated.” Member companies will pledge to limit “sampling” or giving free medicines to doctors to four packets per doctor, and for no longer than two years after the launch of a new drug. (Más)
Ver
Entradas
No hay comentarios:
Publicar un comentario